l and human) involving the device, and the
proposed study protocol and consent documents. Based upon the review of this information,
FDA may impose restrictions on the study to ensure that risks to subjects are minimized
and do not outweigh the anticipated benefits to the subjects and the importance of the
knowledge to be gained. The study may not commence until FDA has approved the IDE
application and the IRB has approved the study. </p>

<p>In contrast, NSR device studies do not require submission 